Ultragenyx (RARE) Jumps: Stock Moves 7.8% Higher
Ultragenyx Pharmaceutical Inc. (RARE) was a big mover last session with its shares rising nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company, as the stock has lost nearly 15% since July 3.
This biotechnology company has seen no estimate revision in the last 7 days. Meanwhile, the Zacks Consensus Estimate has moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if Friday’s rally can turn into more strength down the road.
Ultragenyx currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Investors interested in the biomedical industry may consider better-ranked stocks like Curis, Inc. (CRIS), Biogen Idec Inc. (BIIB) and Actelion Ltd. (ALIOF). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ULTRAGENYX PHARMACEUTICAL INC (RARE): Free Stock Analysis Report
CURIS INC (CRIS): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
Zacks Investment Research